Related Experiment Video
Updated: May 23, 2026

Imaging the Intracellular Trafficking of APP with Photoactivatable GFP
Published on: October 17, 2015
MRP14 (S100A9) protein interacts with Alzheimer beta-amyloid peptide and induces its fibrillization
Ce Zhang1, Yonggang Liu, Jonathan Gilthorpe
1Department of Medical Biochemistry and Biophysics, Umeå University, Umeå, Sweden. phyzce@nus.edu.sg
Abstract:
Increasing evidence supports the contribution of local inflammation to the development of Alzheimer's disease (AD) pathology, although the precise mechanisms are not clear. In this study, we demonstrate that the pro-inflammatory protein S100A9 interacts with the Aβ1-40 peptide and promotes the formation of fibrillar β-amyloid structures. This interaction also results in reduced S100A9 cytotoxicity by the binding of S100A9 toxic species to Aβ1-40 amyloid structures. These results suggest that secretion of S100A9 during inflammation promotes the formation of amyloid plaques. By acting as a sink for toxic species, plaque formation may be the result of a protective response within the brain of AD patients, in part mediated by S100A9.
Insights
Inflammation protein S100A9 binds to amyloid-beta (Aβ) peptides, promoting the formation of Alzheimer's disease (AD) amyloid plaques. This interaction may represent a protective brain response by reducing S100A9 toxicity.
Area of Science:
- Neuroscience
- Immunology
- Biochemistry
Background:
- Local inflammation is increasingly implicated in Alzheimer's disease (AD) pathology.
- The precise mechanisms linking inflammation to AD pathogenesis remain unclear.
Purpose of the Study:
- To investigate the interaction between the pro-inflammatory protein S100A9 and amyloid-beta (Aβ) peptides.
- To elucidate the role of S100A9 in the formation of amyloid structures and its impact on cytotoxicity in the context of AD.
Main Methods:
- Biochemical assays to assess the interaction between S100A9 and Aβ1-40.
- Analysis of fibrillar structure formation.
- Cytotoxicity assays to evaluate the impact of the interaction on cell viability.
Main Results:
- The pro-inflammatory protein S100A9 directly interacts with the Aβ1-40 peptide.
- This interaction promotes the formation of fibrillar β-amyloid structures.
- Binding of S100A9 to Aβ1-40 amyloid structures reduces S100A9-mediated cytotoxicity.
Conclusions:
- Secretion of S100A9 during inflammation contributes to the formation of amyloid plaques in the brain.
- Amyloid plaque formation, in part mediated by S100A9, may serve as a protective mechanism by sequestering toxic S100A9 species in Alzheimer's disease patients.
More Related Videos
09:52Modified Roller Tube Method for Precisely Localized and Repetitive Intermittent Imaging During Long-term Culture of Brain Slices in an Enclosed System
Published on: December 28, 2017
11:57Saccharomyces cerevisiae Models of Alzheimer's Disease to Screen Genes, Mutations, and Chemicals Affecting Amyloid Beta Production by γ-Secretase
Published on: June 24, 2025
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology